Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002405812 | SCV002705929 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-06-01 | criteria provided, single submitter | clinical testing | The p.I527M variant (also known as c.1581C>G), located in coding exon 13 of the BAP1 gene, results from a C to G substitution at nucleotide position 1581. The isoleucine at codon 527 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV003443052 | SCV004169690 | uncertain significance | not provided | 2023-04-03 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Baylor Genetics | RCV003464526 | SCV004214901 | uncertain significance | BAP1-related tumor predisposition syndrome | 2023-05-19 | criteria provided, single submitter | clinical testing |